RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
Menno de Jong appointed director of RIVM Centre for Infectious Disease Control Starting 1 May 2024, Professor Menno de Jong will take on the role of director of RIVM’s Centre for Infectious Disease Control (CIb) . He succeeds Jaap van Dissel, who is retiring in April 2024.
In 2023 more Dutch people play sports on a weekly basis In 2023, 56% of the Dutch population aged four and over played sports at least once a week. This figure marks an increase from 53% in 2022. Notably, the percentage of individuals with physical disabilities who played sports weekly saw a significant rise, from 23% to 29%.
Number of Combined Lifestyle Intervention participants more than doubles in one year The number of participants that has started the Combined Lifestyle Intervention (CLI) has more than doubled over the course of a single year. Nationwide, over 82,000 people have now started the CLI. According to RIVM’s annual report, most of the participants achieve a good outcome.
Adherence to Physical Activity Guidelines particularly low among young adults The number of people in the Netherlands aged four and over who meet the Physical Activity Guidelines has fallen since 2020. In 2022, 44.3% of the population was sufficiently physically active.
Less than half of Dutch people met the Physical Activity Guidelines in 2021 In 2021, 47% of people aged four years and older in the Netherlands got the amount of physical activity recommended by the Physical Activity Guidelines. Children aged 4 to 11 years were most likely to meet the standard. Conversely, young people between the ages of 12 and 17 fell short. This is the outcome of a study conducted by RIVM.
People working from home more likely to have health problems People who worked from home during the COVID-19 pandemic were more likely to have physical complaints than people working on location (location workers). Examples included upper back pain, lower back pain, and pain in arms, neck and/or shoulders. These findings are from RIVM research.
Teen vaccination against meningococcal disease starts From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.
Meningococcal type W most notable infectious disease in 2017 The report ‘State of Infectious Diseases in the Netherlands in 2017’ published by RIVM today, provides an overview of the most important developments in infectious diseases in the Netherlands and a
Meningococcal disease serious, but still rare Meningococcal disease is a disease caused by a bacterium, the meningococcus. There are several types of this bacterium. In most cases, it does not make you ill.